Table 1 Patient characteristics and cycle parameters.
| Â | DGC/SU | DDGC/SU | p value |
|---|---|---|---|
IVF cycles | 306 | 223 | Â |
Primary infertility (%) | 150 (49.0) | 125 (56.0) | 0.1098 |
Infertility duration(years) | 3 [2,4] | 3 [2,5] | 0.6637 |
Age | |||
  Male | 31 [28,35] | 31 [29,36] | 0.2888 |
  Female | 30[28,34] | 31[28,34] | 0.1716 |
BMI | |||
  Male | 24.6 [22.5,27.0] | 24.2 [22.7,27.2] | 0.8179 |
  Female | 21.80 [19.9,24.6] | 22.2 [20.3,24.8] | 0.1638 |
Parameter of semen quality* | |||
  Concentration (106/ml) | 63.2[37.3,97] | 46.3 [28.2,72.9] | 0.0001 |
  Total sperm count (106) | 172.2 [105.7,279.1] | 132 [85.1,242.9] | 0.0038 |
  PR (%) | 47.14 ± 17.49 | 35.48 ± 17.09 | <0.0001 |
  Sperm DFI | 10 [6.9,14.6] | 13.0 [8.6,19.4] | <0.0001 |
  Normal morphology (%) | 4.3 [4.1,4.8] | 4.1[3.7,4.4] | <0.0001 |
Diagnosis | |||
  Tubal (%) | 153 (50) | 99 (44.4) | 0.2024 |
  Endometriosis (%) | 17 (5.6) | 10 (4.5) | 0.5804 |
  Declined ovarian reserve (%) | 31 (10.1) | 28 (12.6) | 0.3815 |
  Male factor (%) | 10 (3.3) | 25 (11.2) | 0.0003 |
Female hormonal level | |||
  Basal FSH, IU/l | 6.6 [5.5,7.9] | 6.4 [5.3,7.6] | 0.1218 |
  Basal LH, IU/l | 4.9 [3.4,7.0] | 4.7 [3.5,6.5] | 0.4462 |
  Base E2, ng/l | 29.8 [18.3,43.9] | 31.1 [18.3,44.8] | 0.7778 |
  AMH, ng/ml | 2.9 [1.5,5.3] | 3.1 [1.6,5.5] | 0.4628 |
GnRH analogues | |||
  Agonist (%) | 153 (50) | 116 (52) | 0.6466 |
  Antagonist (%) | 56 (18.3) | 43 (19.3) | 0.7749 |
  No analogues (%) | 97 (31.7) | 64 (28.7) | 0.5033 |
Total dose of Gn | 2025 [1316,2700] | 1950 [1347,2700] | 0.7650 |
Duration of Gn treatment (days) | 9 [8,10] | 9 [8,10] | 0.7816 |
Endometrial thickness | 8.0 [9.0,10.0] | 8.0 [9.0,11.0] | 0.8737 |
Average oocytes retrieved | 8 [5,12] | 9 [5,13] | 0.2391 |
Average MII oocytes | 8 [5,11] | 8 [5,13] | 0.3899 |
